tradingkey.logo

Heartbeam Inc

BEAT
查看详细走势图
3.100USD
+0.390+14.39%
收盘 12/19, 16:00美东报价延迟15分钟
106.46M总市值
亏损市盈率 TTM

Heartbeam Inc

3.100
+0.390+14.39%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+14.39%

5天

+34.78%

1月

+296.93%

6月

+103.95%

今年开始到现在

+34.78%

1年

+27.57%

查看详细走势图

TradingKey Heartbeam Inc股票评分

单位: USD 更新时间: 2025-10-27

操作建议

当前估值合理,机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价max_target_price。目前股价在压力位和支撑位之间,可以做区间波段操作。

Heartbeam Inc评分

相关信息

行业排名
159 / 204
全市场排名
468 / 4682
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 4 位分析师
买入
评级
3.875
目标均价
+385.04%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Heartbeam Inc亮点

亮点风险
HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
利润高增长
公司净利润处于行业前列,最新年度总收入0.00美元
估值合理
公司最新PE估值-2.32,处于3年历史合理位
机构加仓
最新机构持股3.60M股,环比增加9.65%
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值1.12M

Heartbeam Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Heartbeam Inc简介

HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
公司代码BEAT
公司Heartbeam Inc
CEOEno (Robert P)
网址https://www.heartbeam.com/

常见问题

Heartbeam Inc(BEAT)的当前股价是多少?

Heartbeam Inc(BEAT)的当前股价是 3.100。

Heartbeam Inc的股票代码是什么?

Heartbeam Inc的股票代码是BEAT。

Heartbeam Inc股票的52周最高点是多少?

Heartbeam Inc股票的52周最高点是4.000。

Heartbeam Inc股票的52周最低点是多少?

Heartbeam Inc股票的52周最低点是0.540。

Heartbeam Inc的市值是多少?

Heartbeam Inc的市值是106.46M。

Heartbeam Inc的净利润是多少?

Heartbeam Inc的净利润为-19.45M。

现在Heartbeam Inc(BEAT)的股票是买入、持有还是卖出?

根据分析师评级,Heartbeam Inc(BEAT)的总体评级为买入,目标价格为3.875。

Heartbeam Inc(BEAT)股票的每股收益(EPS TTM)是多少

Heartbeam Inc(BEAT)股票的每股收益(EPS TTM)是-0.661。
KeyAI